Research analysts at B. Riley began coverage on shares of Tango Therapeutics (NASDAQ:TNGX – Get Free Report) in a report issued on Friday, MarketBeat Ratings reports. The firm set a “buy” rating and a $16.00 price target on the stock. B. Riley’s price target would suggest a potential upside of 74.29% from the stock’s previous […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 8,440,000 shares, a growth of 23.0% from the October 15th total of 6,860,000 shares. Currently, 16.1% of the shares of the stock are […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($3.84) per share for the year, […]
StockNews.com initiated coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Several other brokerages also recently issued reports on MRTX. Guggenheim lowered their price objective on shares of Mirati Therapeutics from $104.00 to […]
International Biotechnology Trust PLC grew its position in shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) by 6.6% in the 2nd quarter, Holdings Channel reports. The firm owned 260,000 shares of the biotechnology company’s stock after acquiring an additional 16,000 shares during the quarter. Mirati Therapeutics accounts for about 2.9% of International Biotechnology Trust […]